Abstract. Calcium metabolism and plasma concentrations of vitamin D metabolites were investigated in 27 children on long-term anticonvulsant therapy. Serum calcium was in the low normal range, phosphorus was normal, parathyroid hormone concentrations and alkaline phosphatase were elevated. Plasma 25-hydroxyvitamin D (25-OH D) and 24,25-dihydroxyvitamin D (24,25-(OH)2D) were decreased, but 1,25-dihydroxyvitamin D (1,25-(OH)2D) was normal when compared with a synchronous control group. The serum concentrations of all anticonvulsant drugs given were measured. The decreases in 25-OH D and 24,25-(OH)2D did not depend on the blood level of a single drug, or any combination of drugs given, or on the duration of therapy. The 25-OH D levels were negatively correlated with the number of different drugs used, which may reflect the severity of the neurologic disorder, and therefore with non-specific factors such as exposure to sunlight, nutrition, or physical activity.Our data do not support the hypothesis that anticonvulsant drugs act on vitamin D metabolism. Key words: Calcium metabolism -Vitamin D metabolites - Anticonvulsant drugsAnticonvulsant drugs, particularly diphenylhydantoin (DPH) and phenobarbital (PB), are known to affect calcium metabolism and to cause rickets or osteomalacia [1,2]. In vitro, in the rat, Caspary [3] and Koch et al. [4] found that intestinal absorption of calcium was depressed by DPH but not by PB. The amounts of the vitamin D dependent calcium binding were found to be normal [3].Since PB induces hepatic microsomal enzymes, it has been suggested that due to increased 25-hydroxylase activity PB may increase the availability of25-OH D and its conversion to more polar but less active vitamin D metabolites, thus enhancing plasma clearance of vitamin D and leading to reduced serum and tissue levels of active vitamin D metabolites [5][6][7]. Conversely, in patients receiving anticonvulsant therapy plasma levels of 24,25-(OH)2D were decreased [8], and levels of 1,25-(OH)2D were reported to be normal [9]. It was concluded that in the presence of PB the intestine is less responsive to 1,25-(OH)2D, or that other factors than vitamin D metabolites may impair intestinal calcium transport. [10] found that in epileptic patients on anticonvulsant therapy absorption of calcium from the digestive tract was moderately depressed but that small doses of 1,25-(OH)2D as well as 25-OH D enhanced calcium absorption. They concluded that the sensitivity of the intestine to vitamin D was not impaired in these subjects. These results may indicate that in patients on anticonvulsant therapy the serum calcium, phosphorus, alkaline phosphatase, and parathyroid hormone (PTH) abnormalities are not caused by a defect in 1,25-(OH)2D metabolism or action on the intestine. As vitamin D metabolism is particularly influenced by external factors such as seasonal changes and differences in exposure to sunlight, physical activity and nutritional status, control data may be derived only from carefully matched subjects. This was also cons...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.